Evidence map›Paper›PMID 42218117›Full record

ArticleThe Journal of physiology2026

Functional role of Nav1.8 channels in action potentials of mouse CGRP-lineage dorsal root ganglion neurons.

Tomás Osorno, Robert G Stewart, Akie Fujita, Sooyeon Jo, Bruce P Bean

Abstract read
In one paragraph

Article in The Journal of physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tomás OsornoDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Robert G StewartDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Akie FujitaDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Sooyeon JoDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.
Bruce P BeanDepartment of Neurobiology, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0002-5093-3576

Funding

Ion Channel Pharmacology for Pain and EpilepsyR35NS127216 · NINDS · HARVARD MEDICAL SCHOOL · PI BRUCE P BEAN · 2022 to 2026
$3.6M
NIH HHSNINDS NIH HHS R35 NS127216
6 · The paper itself

Abstract

Primary sensory neurons that sense noxious stimuli (nociceptors) are unusual in possessing two major components of voltage-dependent sodium channel current with different voltage dependence and kinetics. We used pharmacology to characterize the roles of defined sodium channel types in generating action potentials and controlling repetitive firing in putative peptidergic nociceptors, using mice in which CGRP-lineage neurons are fluorescently labelled. We found that the major components of sodium current were carried by Nav1.8 channels, identified by sensitivity to VX-548 (suzetrigine), and by Nav1.7 channels, identified by sensitivity to the toxin GsAF-1, with an additional smaller component of current carried by tetrodotoxin-sensitive channels resistant to GsAF-1. Action potential clamp experiments were used to quantify the size and time course of the Nav1.8 component of sodium current during firing of single and repetitive action potentials. In most neurons, Nav1.8 current carried the majority of overall sodium entry during action potentials and nearly all of the sodium current supporting action potentials during repetitive firing. Although total tetrodotoxin-sensitive current (mostly but not entirely carried by Nav1.7 channels) activated with smaller depolarizations and much more rapidly than Nav1.8 current, Nav1.8 current was equally important in setting the action potential threshold and was dominant in the action potential upstroke because of its greater size. By comparison with similar experiments in human dorsal root ganglion neurons, the results suggest Nav1.8 channels play a more dominant role in firing of mouse peptidergic nociceptors than in human C-type nociceptors, suggesting limitations of pharmacology of mouse nociceptors for predicting effects on human nociceptor excitability. KEY POINTS: The new Nav1.8 inhibitor VX-548 (suzetrigine) was used to define the role of Nav1.8 currents in generating action potentials in mouse CGRP-lineage dorsal root ganglion neurons. Nav1.8 current typically carried the majority of sodium current evoked by voltage steps, with remaining current mainly carried by Nav1.7 channels (identified by sensitivity to GsAF-1) together with a small component from tetrodotoxin-sensitive channels not inhibited by GsAF-1. Nav1.8 current contributes to determining the action potential threshold, provides the majority of sodium current during the rising phase of the action potential and flows during the shoulder of the action potential typical of C-fibre nociceptors. Inhibition of Nav1.8 sodium current by VX-548 produces a counter-intuitive decrease in refractory period, probably resulting from reduction of potassium channel activation caused by a smaller peak and narrower action potential when Nav1.8 current is inhibited.

Indexed as

Action PotentialsCalcitonin Gene-Related PeptideGanglia, SpinalNAV1.8 Voltage-Gated Sodium ChannelNeuronsNociceptorsAnimalsMaleMiceMice, Inbred C57BLNAV1.7 Voltage-Gated Sodium ChannelSodium Channel BlockersTetrodotoxinCalcitonin Gene-Related PeptideNAV1.7 Voltage-Gated Sodium ChannelNAV1.8 Voltage-Gated Sodium ChannelScn10a protein, mouseSodium Channel BlockersTetrodotoxinGsAF‐1nociceptorsodium channelsuzetriginetetrodotoxinVX‐548

Identifiers

PMID42218117
PMCPMC13271011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.